UroGen Pharma Ltd. SEC filings URGN
UroGen Pharma Ltd. has 583 filings in SEC EDGAR's recent list, going back to Mar 4, 2016. Its latest annual report, Form ARS, was filed on May 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Nov 4, 2026 | — |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 9, 2026 | Oct 8, 2026 |
| 144 | Notice of proposed sale | Oct 9, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 7, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 7, 2026 |
| 144 | Notice of proposed sale | Sep 9, 2026 | — |
| 144 | Notice of proposed sale | Sep 9, 2026 | — |
| 4 | Insider transaction | Aug 28, 2026 | Aug 26, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 144 | Notice of proposed sale | Aug 20, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 20, 2026 | Aug 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 144 | Notice of proposed sale | Jul 9, 2026 | — |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results
|
Jun 23, 2026 | Jun 22, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 9, 2026 | Jun 8, 2026 |
| 144 | Notice of proposed sale | Jun 9, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 2, 2026 | Jun 2, 2026 |
| ARS | Annual report to shareholders | May 27, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | May 27, 2026 | May 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | May 11, 2026 | May 8, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 27, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Jan 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 11, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 144 | Notice of proposed sale | Feb 3, 2026 | — |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 19, 2025 |
| 144 | Notice of proposed sale | Nov 19, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| S-3ASR | Automatic shelf registration | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Sep 9, 2025 | Sep 7, 2025 |
| 4 | Insider transaction | Sep 9, 2025 | Sep 7, 2025 |
| 144 | Notice of proposed sale | Sep 9, 2025 | — |
| 144 | Notice of proposed sale | Sep 9, 2025 | — |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 27, 2025 | Aug 26, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 6, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| 4 | Insider transaction | Jul 30, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| 144 | Notice of proposed sale | Jul 29, 2025 | — |
| 144 | Notice of proposed sale | Jul 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| ARS | Annual report to shareholders | Jul 16, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jul 15, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 16, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 13, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 8, 2025 |
| 144 | Notice of proposed sale | Jun 10, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 17, 2025 | — |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 20, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 14, 2025 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 18, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 4 | Insider transaction | Oct 9, 2024 | Oct 8, 2024 |
| 3 | Initial insider ownership | Oct 9, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2024 | Oct 7, 2024 |
| 8-K |
Current report
New debt
|
Sep 24, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 9, 2024 |
| 144 | Notice of proposed sale | Sep 10, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 15, 2024 | Aug 14, 2024 |
| S-8 | Employee stock plan registration | Aug 13, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| ARS | Annual report to shareholders | Jul 9, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Jul 1, 2024 | — |
| DEF 14A | Proxy statement | Jul 1, 2024 | Aug 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Jun 24, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jun 24, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2024 | Jun 17, 2024 |
| 424B5 | Prospectus supplement | Jun 18, 2024 | — |
| 424B5 | Prospectus supplement | Jun 17, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 10, 2024 |
| 144 | Notice of proposed sale | Jun 11, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | May 8, 2024 | — |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 20, 2024 | Mar 18, 2024 |
| 144 | Notice of proposed sale | Mar 18, 2024 | — |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 1, 2024 | Mar 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 22, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4/A | Form 4/a | Feb 12, 2024 | Jan 31, 2024 |
| 4/A | Form 4/a | Feb 12, 2024 | Mar 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 7, 2024 | Feb 7, 2024 |
| 4/A | Form 4/a | Feb 5, 2024 | Jan 31, 2024 |
| 4/A | Form 4/a | Feb 5, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 2, 2024 | — |
| 144 | Notice of proposed sale | Feb 1, 2024 | — |
| 144 | Notice of proposed sale | Feb 1, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jan 17, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 2, 2024 | Dec 28, 2023 |
| SC 13G | Ownership over 5% (passive) | Dec 29, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2023 | — |
| CORRESP | Letter to the SEC | Nov 27, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| S-8 | Employee stock plan registration | Nov 14, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| EFFECT | Filing | Sep 15, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- URGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ra'Anana, Israel
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1668243
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.